Willow Biosciences Inc. (WLLW.TO) TSX
Currency In CAD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CAD
Address
202, 1201-5th Street SW
Calgary, AB T2R 0Y6
Canada
Phone
403 910 5140
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
19
First IPO Date
February 11, 2021
| Name | Title | Pay | Year Born |
| Travis Doupe | Chief Financial Officer & Interim Chief Executive Officer | 300,475 | 1971 |
| Chris Savile | President, Director & Chief Executive Officer | 607,371 | N/A |
| Trish Choudhary | Senior Vice President of Research & Development | 453,896 | N/A |
| Sanjib Singh Gill | Corporate Secretary | 0 | 1976 |
Founded in 1981 and headquartered in Calgary, Canada, Willow Biosciences Inc. operates as a biotechnology enterprise. The company is dedicated to the creation, manufacturing, and distribution of plant-derived compounds, primarily serving the consumer care, food and beverage, and pharmaceutical industries across Canada. A core part of its product portfolio includes cannabidiol (CBD), cannabigerol (CBG), and various varin cannabinoids, such as cannabigerovarin (CBGV), cannabidivarin (CBDV), and tetrahydrocannabivarin (THCV).